Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Clinical characteristics and treatment outcomes of primary autoimmune hemolytic anemia: a single center study from South India.

Prabhu R, Bhaskaran R, Shenoy V, G R, Sidharthan N.

Blood Res. 2016 Jun;51(2):88-94. doi: 10.5045/br.2016.51.2.88. Epub 2016 Jun 23.

2.

Clinical characteristics and long-term outcomes of warm-type autoimmune hemolytic anemia.

Rattarittamrong E, Eiamprapai P, Tantiworawit A, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Norasetthada L.

Hematology. 2016 Jul;21(6):368-74. doi: 10.1080/10245332.2016.1138621. Epub 2016 Mar 21.

PMID:
27077773
3.

Warm autoimmune hemolytic anemia: experience from a single referral center in Mexico City.

Alonso HC, Manuel AV, Amir CG, Sergio RR, Allan P, Xavier LK, Juventina TE.

Blood Res. 2017 Mar;52(1):44-49. doi: 10.5045/br.2017.52.1.44. Epub 2017 Mar 27.

4.

Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.

Reynaud Q, Durieu I, Dutertre M, Ledochowski S, Durupt S, Michallet AS, Vital-Durand D, Lega JC.

Autoimmun Rev. 2015 Apr;14(4):304-13. doi: 10.1016/j.autrev.2014.11.014. Epub 2014 Dec 9.

PMID:
25497766
5.

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients.

Barcellini W, Fattizzo B, Zaninoni A, Radice T, Nichele I, Di Bona E, Lunghi M, Tassinari C, Alfinito F, Ferrari A, Leporace AP, Niscola P, Carpenedo M, Boschetti C, Revelli N, Villa MA, Consonni D, Scaramucci L, De Fabritiis P, Tagariello G, Gaidano G, Rodeghiero F, Cortelezzi A, Zanella A.

Blood. 2014 Nov 6;124(19):2930-6. doi: 10.1182/blood-2014-06-583021. Epub 2014 Sep 16.

PMID:
25232059
6.

Venous thromboembolism related to warm autoimmune hemolytic anemia: a case-control study.

Lecouffe-Desprets M, Néel A, Graveleau J, Leux C, Perrin F, Visomblain B, Artifoni M, Masseau A, Connault J, Pottier P, Agard C, Hamidou M.

Autoimmun Rev. 2015 Nov;14(11):1023-8. doi: 10.1016/j.autrev.2015.07.001. Epub 2015 Jul 8. Review.

PMID:
26162301
7.

Immunotherapy treatments of warm autoimmune hemolytic anemia.

Liu B, Gu W.

Clin Dev Immunol. 2013;2013:561852. doi: 10.1155/2013/561852. Epub 2013 Sep 11. Review.

8.

Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case report.

Gupta S, Szerszen A, Nakhl F, Varma S, Gottesman A, Forte F, Dhar M.

J Med Case Rep. 2011 Apr 19;5:156. doi: 10.1186/1752-1947-5-156.

9.

Refractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy.

Ma K, Caplan S.

Case Rep Hematol. 2016;2016:9181698. doi: 10.1155/2016/9181698. Epub 2016 Mar 22.

10.

[A new approach for diagnosis of autoimmune hemolytic anemia].

Kajii E, Omi T, Miura Y, Ikemoto S.

Rinsho Ketsueki. 1994 Apr;35(4):336-40. Japanese.

PMID:
8028177
11.

Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.

D'Arena G, Califano C, Annunziata M, Tartarone A, Capalbo S, Villani O, Amendola G, Pietrantuono G, Ferrara F, Pinto A, Musto P, D'Arco AM, Cascavilla N.

Eur J Haematol. 2007 Jul;79(1):53-8. Epub 2007 May 28.

PMID:
17532766
12.

Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases.

Baek SW, Lee MW, Ryu HW, Lee KS, Song IC, Lee HJ, Yun HJ, Kim S, Jo DY.

Korean J Hematol. 2011 Jun;46(2):111-7. doi: 10.5045/kjh.2011.46.2.111. Epub 2011 Jun 21.

13.

Characteristics and outcome of warm autoimmune hemolytic anemia in adults: New insights based on a single-center experience with 60 patients.

Roumier M, Loustau V, Guillaud C, Languille L, Mahevas M, Khellaf M, Limal N, Noizat-Pirenne F, Godeau B, Michel M.

Am J Hematol. 2014 Sep;89(9):E150-5. doi: 10.1002/ajh.23767. Epub 2014 Jun 19.

14.

Treatment of autoimmune hemolytic anemias.

Zanella A, Barcellini W.

Haematologica. 2014 Oct;99(10):1547-54. doi: 10.3324/haematol.2014.114561. Review.

15.

Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemia.

Kulpa J, Skrabs C, Simanek R, Valent P, Panzer S, Lechner K, Sillaber C, Jäger U.

Wien Klin Wochenschr. 2016 Apr;128(7-8):234-7. doi: 10.1007/s00508-015-0863-y. Epub 2015 Sep 24.

PMID:
26404740
16.

Incidence and risk factors of relapses in idiopathic autoimmune hemolytic anemia.

Dussadee K, Taka O, Thedsawad A, Wanachiwanawin W.

J Med Assoc Thai. 2010 Jan;93 Suppl 1:S165-70.

PMID:
20364571
17.

Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation.

Drobyski WR, Potluri J, Sauer D, Gottschall JL.

Bone Marrow Transplant. 1996 Jun;17(6):1093-9.

PMID:
8807120
18.

Classification and therapeutic approaches in autoimmune hemolytic anemia: an update.

Michel M.

Expert Rev Hematol. 2011 Dec;4(6):607-18. doi: 10.1586/EHM.11.60. Review.

PMID:
22077525
19.

Treatment of autoimmune hemolytic anemia: real world data from a reference center in Mexico.

Jaime-Pérez JC, Aguilar-Calderón P, Salazar-Cavazos L, Gómez-De León A, Gómez-Almaguer D.

Blood Res. 2019 Jun;54(2):131-136. doi: 10.5045/br.2019.54.2.131. Epub 2019 Jun 25.

20.

[Characteristics of warm autoimmune hemolytic anemia and Evans syndrome in adults].

Michel M.

Presse Med. 2008 Sep;37(9):1309-18. doi: 10.1016/j.lpm.2008.01.026. Epub 2008 Jul 17. Review. French.

PMID:
18644324

Supplemental Content

Support Center